Isolation of Isoflavones and Soyasaponins from the Germ of Soybean |
Kim, Sun-Lim
(National Institute of Crop Science RDA)
Lee, Jae-Eun (National Institute of Crop Science RDA) Kim, Yul-Ho (National Institute of Crop Science RDA) Jung, Gun-Ho (National Institute of Crop Science RDA) Kim, Dea-Wook (National Institute of Crop Science RDA) Lee, Choon-Ki (National Institute of Crop Science RDA) Kim, Mi-Jung (National Institute of Crop Science RDA) Kim, Jung-Tae (National Institute of Crop Science RDA) Lee, Yu-Young (National Institute of Crop Science RDA) Hwang, Tae-Young (National Institute of Crop Science RDA) Lee, Kwang-Sik (National Institute of Crop Science RDA) Kim, Wook-Han (National Institute of Crop Science RDA) Kwon, Young-Up (National Institute of Crop Science RDA) Kim, Hong-Sig (Department of Crop Science, Chungbuk National University) Chung, Ill-Min (Department of Molecular Biotechnology, KonKuk University) |
1 | Wang, H., and P. Murphy. 1994. Isoflavone composition of American and Japanese soybeans in Iowa: Eff ects of variety, crop year and location. J. Agric. Food Chem. 42: 1674-1677. DOI ScienceOn |
2 | Yoshiki Y., S. Takagi, M. Watanabe, and K. Okubo, 2005. Fractionation of soybean functional glycosides from soywaste based on the chemical reaction of soyasaponin g. Food Chemistry. 93:591-597. DOI ScienceOn |
3 | Yoshiki, Y. M. Kinumi, T. Kahara, and K. Okubo. 1996. Chemiluminescence of soybean saponins in the presence of active oxygen species. Plant Science. 116:125-129. DOI ScienceOn |
4 | Yoshikoshi, M., Y. Yoshiki, K. Okubo, J. Seto, and Y. Sasaki. 1996. Prevention of hydrogen peroxide damage by soybean saponins to mouse fibroblasts. Planta Med. 62: 252-255. DOI ScienceOn |
5 | Miyao, H., T. Arao, M. Udayama, J. Kinjo, and T. Nohara. 1998. Kaikasaponin III and soyasaponin I, major triterpenesaponins of Abruscantoniensis, act on GOT and GPT; influence on transaminase elevation of rat liver cells concomitantly exposed to CCl4 for one hour. Planta Med. 64:5-7. DOI ScienceOn |
6 | Rao, A. V. and M. K. Sung. 1995. Saponins as anticarcinogens. J. Nutr. 125:717S-724S. |
7 | Sanders, T. A. B., S. D. Tracey, G. David, J. M. George, and W. Helen. 2002. Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am. J. Clin. Nutr. 76(2):373-377. |
8 | Sarkar, F. H. and Y. Li. 2003. Soy isoflavones and cancer prevention. Cancer Invest. 21:817-818. DOI ScienceOn |
9 | Scheiber M. D., J. H. Liu, M. T. Subbiah, R. W. Rebar, and K. D. Setchell. 2001. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause. 8(5):384-392. DOI ScienceOn |
10 | Setchell K. D., N. M. Brown, and E. Lydeking-Olsen. 2002. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132(12):3577-3584. |
11 | Setchell, K. D. and A. Cassidy. 1999. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:758S-767S. |
12 | Shiraiwa, M., S. Kudou, M. Shimoyamada, K. Harada, and K. Okubo, 1991. Composition and structure of "group A saponin" in soybean seed. Agric. Biol. Chem. 55:315-322 & 55:911-917. DOI |
13 | Tikkanen, M. J. and H. Adlercreutz. 2000. Dietary soyderived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem. Pharmacol. 60(1):1-5. DOI ScienceOn |
14 | Sirtor, C. R. 2001. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf. 24(9):665-682. DOI ScienceOn |
15 | Taniyama T., Y. Nagahama, M. Yoshikawa, and I. Kitagawa. 1988. Saponin and sapogenol. XLIII. acetyl-soyasaponins A4, A5, and A6, new astringent bisdesmosides of soyasapogenol A, from Japanese soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2829-2839. DOI |
16 | Tham, D. M., C. D. Gardner, and W. L. Haskell. 1998. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83(7):2223-2235. DOI |
17 | Tsukamoto, C., A. Kikuchi, K. Harada, K. Kitamura, and K. Okubo. 1993. Genetic and chemical polymorphisms of saponins in soybean seed. Phytochemistry. 34(5):1351-1356. DOI ScienceOn |
18 | Vlietinck, A. J., T. De Bruyne, S. Apers, and L. A. Pieters. 1998. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 64:97-109. DOI ScienceOn |
19 | Diane F. B., H. Suzanne, and W. Wang. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics. 90:157-177. DOI ScienceOn |
20 | Hayashi, K, H. Hayashi, N. Hiraoka, and Y. Ikeshiro. 1997. Inhibitory activity of soyasaponin II on virus replication in vitro. Planta Medica, 63, 102-105. DOI ScienceOn |
21 | Hu, J.; S. O. Lee, S. Hendrich, and P. A. Murphy. 2002. Quantification of the group B soyasaponins by highperformance liquid chromatography. J. Agric. Food Chem. 50:2587-2594. DOI ScienceOn |
22 | Kitagawa I., T. Taniyama, Y. Nagahama, K. Okubo, F. Yamauchi, and M. Yoshikawa. 1988b. Saponin and sapogenol. XLII. Structures of acetyl-soyasaponins A1, A2, and A3, astringent partially acetylated bisdesmosides of soyasapogenol A, from American soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2819-2828. DOI |
23 | Iwamura J. and Kashiwara. 1984. Process for isolating saponins and flavonoids from leguminous plants. United State Patent. 4,428,876 (Jan. 31). |
24 | Kinjo, J., M. Imagire, M. Udayama, T. Arao, and T. Nohara. 1988. Structure-hepatoprotective relationships study of soyasaponins I-IV having soyasapogenol B as aglycone. Planta Med. 64:233-236. |
25 | Kitagawa I., H. K. Wang, T. Taniyama, and M. Yoshikawa. 1988a. Saponin and sapogenol. XLI. Reinvestigation of the structures of soyasapogenols A, B, and E, oleanenesapogenols from soybean. Structures of soyasaponins I, II, and III. Chem. Pharm. Bull. 36: 153-161. DOI |
26 | Konoshima, T., M. Kokumai, M. Kozuka, H. Tokuda, H. Nishino, and A. Iwashima. 1992. Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys. J Nat Prod 55:1776-1778. DOI |
27 | Koratkar, R. and A. V. Rao. 1997. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer. 27:206-209. DOI ScienceOn |
28 | Kudou, S., M. Tonomura, C. Tsukamoto, M. Shimoyamada, T. Uchida, and K. Okubo. Isolation and structural elucidation of the major genuine soybean saponin. Biosci. Biotechnol. Biochem. 1992, 56:142-143. DOI ScienceOn |
29 | Lichtenstein, A. H. 2001. Got Soy ? (Editorial). Am. J. Clin. Nutr. 73(4):667-668. |
30 | Liu, K. S. 1997. Soybeans: Chemistry, tchnology and uilization, Springer. p. 4-5. |
31 | Anderson, R. L. and W. J. Wolf. 1995. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125: 581S-588S. |
32 | Shibuya M., K. Nishimura, N. Yasuyama, and Y. Ebizuka. 2010. Identification and characterization of glycosyltransferases involved in the biosynthesis of soyasaponin I in Glycine max. FEBS Letters. 584:2258-2264. DOI ScienceOn |
33 | Messina M. J., V. Persky, K. D. Setchell, and S. Barnes. 1994. Soya intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 21:113-131. DOI ScienceOn |
34 | Miksicek, R. J. 1994. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49(2-3): 153-160. DOI ScienceOn |
35 | Ariyo, A. A. and A. C. Villablanca. 2002. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad Med. 111(1):23-30. |
36 | Barnes, S. 1998. Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med. 271(3):386-392. |
37 | Berhow, M. A. E. D. Wagner, S. F. Vaughn, and M. J. Plewa. 2000. Characterization and antimutagenic activity of soybean saponins. Mutation Research. 448:11-22. DOI ScienceOn |
38 | Berhow, M. A., S. B. Kong, K. E. Vermillion, and S. M. Duval. 2006. Complete quantification of group A and group B soyasaponins in soybeans. J. Agric. Food Chem. 54:2035-2044. DOI ScienceOn |
39 | Choi, Y. B. and H. S. Sohn. 1997. Recovery of isoflavones from soybean cooking water produced during soymilk manufacturing process. Korean J. Food Sci. Technol., 29: 522-526. 과학기술학회마을 |
40 | Clarkson, T. B. 2002. Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 132:566S-569S. |
41 | Decroos, K., J. P. Vincken, L. Heng, R. Bakker, H. Gruppen, and W. Verstraete. 2005. Simultaneous quantification of differently glycosylated, acetylated, and 2,3-dihydro-2, 5-dihydroxy-6-methyl-4H-pyran-4-one-conjugated soyasaponins using reversed-phase high-performance liquid chromatography with evaporative light scattering detection. J. Chromatogr. A. 1072:185-193. DOI ScienceOn |